<DOC>
	<DOCNO>NCT00422656</DOCNO>
	<brief_summary>The purpose research study assess response rate perifosine patient relapse refractory Waldenstrom 's macroglobulinemia . Perifosine newly discover compound kill Waldenstrom cell laboratory experiment . Perifosine use research treatment type cancer multiple myeloma .</brief_summary>
	<brief_title>Perifosine Patients With Relapsed/Refractory Waldenstrom 's Macroglobulinemia</brief_title>
	<detailed_description>- Participants give study medication-dosing diary treatment cycle . Each treatment cycle last 28 day . Participants receive 6 cycle study treatment perifosine 6 cycle give one another . - Medication take orally day food go bed dose may reduce schedule change event participant experience side effect . - On Day one cycle , routine blood test exams perform . - At end cycle 2 follow procedure perform ; history physical exam , routine blood test , bone marrow aspirate biopsy CT scan . - At end cycle 6 ( end study ) follow procedure perform ; routine blood test , history physical exam , bone marrow biopsy aspirate , research bone marrow blood sample CT scan . - Participants study 6 month follow every three year 2 year . They may continue study treatment indefinitely disease progression discretion treat investigator .</detailed_description>
	<mesh_term>Waldenstrom Macroglobulinemia</mesh_term>
	<criteria>18 year age old Must receive prior therapy WM relapse refractory WM . Any number prior therapy acceptable Measurable disease , define presence immunoglobulin M paraprotein minimum IgM level equal great 2 time ULN 10 % lymphoplasmacytic cell bone marrow ECOG Performance Status 0,1 , 2 Laboratory value describe protocol Life expectancy great 12 week Uncontrolled infection Other active malignancy CNS involvement Cytotoxic chemotherapy le 3 week , biologic therapy le 2 week , corticosteroid less 2 week prior registration . Other concurrent chemotherapy , immunotherapy , radiotherapy , ancillary therapy consider investigational Pregnant nursing woman Known HIV positive Radiation therapy le 2 week prior registration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>relapse Waldenstrom 's Macroglobulinemia</keyword>
	<keyword>refractory Waldenstrom 's Macroglobulinemia</keyword>
	<keyword>WM</keyword>
	<keyword>perifosine</keyword>
</DOC>